Shimadzu Introduces New Angiography System with AI

Shimadzu Medical Systems USA launched the Trinias angiography system at the Society of Interventional Radiology (SIR) 2022 Annual Meeting.

The new Trinias system uses AI deep learning technology to improve the visibility of medical devices while using 40% or more lower X-ray dose than the company’s previous models under standard dose ratio (Air Kerma) at 7.5pps and 10pps. According to the company, this represents the first time AI has been incorporated into the image processing engine of an angiography system.

An extensive new feature set to simplify workflow on the Trinias system allows for a more efficient clinical operation in any medical setting. With the launch of a subscription service that ensures software can always be updated to the current version, the new Trinias system offers a sustainable product designed for long-term use.

To support the increased use of low-dose operation of angiography systems by medical facilities and ever-smaller therapeutic devices that reduce the burden on patients, Shimadzu has developed SCORE Opera, a new image processing technology that uses AI to ensure catheterization procedures are safe even at low radiation doses.